REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmacorp Ecza Deposu A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Farmacorp Ecza Deposu Sanayi Ve Ticaret Anonim Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Farmacorp Ecza Deposu A.S. is an enterprise based in Turkiye. Its main office is in Ankara. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on March 02, 2012. There are currently 12 (2023) people employed by Farmacorp Ecza Deposu A.S.. From the latest financial highlights, Farmacorp Ecza Deposu A.S. reported a net sales revenue increase of 118.24% in 2022. There was a total growth of 132.55% in Farmacorp Ecza Deposu A.S.’s total assets over the same period. In 2022, Farmacorp Ecza Deposu A.S.’s net profit margin increased by 3.49%.

Headquarters
No:4a Turgut Ozal Mahallesi 2180 Sokak Yenimahalle
Ankara; Central Anatolia; Postal Code: 06370

Contact Details: Purchase the Farmacorp Ecza Deposu A.S. report to view the information.

Website: http://www.farmacorp.com.tr

Basic Information
Total Employees:
Purchase the Farmacorp Ecza Deposu A.S. report to view the information.
Outstanding Shares:
Purchase the Farmacorp Ecza Deposu A.S. report to view the information.
Incorporation Date:
March 02, 2012
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Farmacorp Ecza Deposu A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
118.24%
Total operating revenue
118.24%
Operating profit (EBIT)
56.67%
Net Profit (Loss) for the Period
2975.47%
Total assets
132.55%
Total equity
17.99%
Operating Profit Margin (ROS)
-2.38%
Net Profit Margin
3.49%
Return on Equity (ROE)
12.59%
Debt to Equity Ratio
-20.77%
Quick Ratio
-0.58%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?